期刊文献+

免疫抑制剂在卵巢功能保护应用中的研究进展 被引量:14

Advances in research on ovarian protection of immunosuppressants
在线阅读 下载PDF
导出
摘要 近年来,在社会、环境及医源性因素影响下,女性不孕症的发病率显著上升且趋于年轻化,卵巢功能提前耗竭是主要的原因之一。针对肿瘤放化疗、自身免疫性疾病等原因所致的卵巢储备功能减退(DOR)、早发性卵巢功能不全(POI)或卵巢早衰(POF),保护卵巢功能、延缓卵巢功能的下降、保留患者的生育机会是急需解决的问题。目前,免疫抑制剂广泛应用于器官移植及自身免疫性疾病的治疗,也有部分研究将免疫抑制剂应用于POF动物模型或POF患者中进行卵巢功能保护,本文将首次就这一问题进行文献综述。 In recent years,under the influence of social,environmental and iatrogenic factors,and the incidence of infertility has increased significantly and tend to be younger.The early decline of ovarian function is one of the main reasons.For patients with diminished ovarian reserve(DOR),premature ovarian insufficiency(POI)or premature ovarian failure(POF)caused by tumor radiotherapy and chemotherapy,autoimmunity and so on,how to restore or delay the decline of ovarian function,and therefor preserve the fertility of these patients has become an urgent issue.Currently,immunosuppressive agents are widely used in the treatment of organ transplantation and autoimmune diseases,and studies have applied immunosuppressants to POF animal models or POF patients for ovarian function protection.This paper reviews the literature on this issue.
作者 袁丽芳 黄伟育 覃爱平 杨一华 YUAN Li-fang;HUANG Wei-yu;QIN Ai-ping;YANG Yi-hua(The First Affiliated Hospital of Guangxi Medical University,Nanning 530000)
出处 《生殖医学杂志》 CAS 2021年第1期131-135,共5页 Journal of Reproductive Medicine
基金 广西自然科学基金(2018JJD140073)。
关键词 免疫抑制剂 早发性卵巢功能不全 卵巢早衰 卵巢保护作用 Immunosuppressant Premature ovarian insufficiency Premature ovarian failure Ovarian protection
  • 相关文献

参考文献1

二级参考文献9

  • 1付莉,赵怡璇,李守柔.卵巢早衰实验动物模型的建立[J].生殖医学杂志,2006,15(3):179-183. 被引量:46
  • 2Wang Wei, Li Jijun. Progression of the study of the etiology of premature ovary failure [ J ]. Progress in Obstetrics and Gynecology,2002, 11 (2) :136-137.
  • 3Tung K, Agersborg S, Bagavant H, et al. Autoimmune ovarian disease induced by immunization with zona pellucida (ZP3) peptide [ J]. Curr Protoc Immunol, 2002, 15: 15-17.
  • 4Burnstein K I, Cidlowski J A. The down side of glueocorticoid receptor[ J ] . Mol Cell Endocrinol, 1992,83 ( 1 ) : 1-8.
  • 5Cowchock F S, McCabe J L, Montgomery B B. Pregnancy after corticosteroid administration in premature ovarian failure ( polyglandular endocrinopathy syndrome ) [ J ] . Am J Obstet Gynecol,1988,158(1) :118-119.
  • 6Korczowska I, Lacki J K, Leszczynski P, et al. Bone tissue metabolism in systematic lupus erythematosus patients treated with glucocorticoids [ J ]. Pol Arch Med Wewn, 2001 ,106(14) :901 -907.
  • 7Jacobson D L, Grange S J, Rose N R, et al. Epidemiology and estimated population burden of selected autoimmune diseases in the United States [ J ]. Clin Immunol Immunopathol, 1997 , 84 ( 3 ) :223-243.
  • 8Loria R M. Immune up-regulation and tumor apoptosis by androstene steroids [J]. Steroids,2002,67(12) :953- 966.
  • 9姚根宏,侯亚义,韩晓冬.雄激素对免疫系统的影响[J].中华男科学杂志,2001,7(6):401-403. 被引量:5

共引文献15

同被引文献163

引证文献14

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部